rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CYRX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Cryoport (CYRX) Stock Looks Fully Priced Following Its 129% Rebound
      Nov 13Yahoo FinanceCYRX
      Cryoport director Daniel Hancock sells $1.5M of stock
      Nov 13Investing.comCYRX
      Cryoport CSO Mark Sawicki sells $199,261 in company stock
      Nov 13Investing.comCYRX
      Does Raised Revenue Guidance Change The Bull Case For Cryoport (CYRX)?

      Cryoport reported third quarter 2026 revenue of US$50.22 million compared to US$44.23 million a year earlier, with a wider net loss of US$10.85 million and basic loss per share of US$0.25. The business lifted full year 2026 revenue guidance to a range of US$197 million to US$199 million, highlighting confidence in demand for its services despite ongoing losses. We will now examine how Cryoport's raised 2026 revenue guidance could reshape the existing investment narrative around its growth...

      Nov 12Yahoo FinanceCYRX
      Why Cryoport (CYRX) Shares Climbed After Its Latest Update?

      Cryoport (CYRX) has become a talking point after its third quarter 2026 report, which paired higher revenue with a wider loss and an increase in full year sales guidance to US$197 million to US$199 million. The guidance hike has landed in a market that was already re-rating Cryoport, with the share price at US$20.47 after a 7.17% 1-day move and a 114.12% year-to-date share price return. The 1-year total shareholder return of 139.70% points to strong recent momentum despite a 5-year total...

      Nov 10Yahoo FinanceCYRX
      Cryoport Needs To Chill Down (Downgrade) (NASDAQ:CYRX)
      Nov 9Seeking AlphaCYRX
      What Comes Next For Cryoport After A 100% Gain

      If Cryoport was on your watchlist rather than in your portfolio over 2026, the outcome may feel like a missed shot. For Cryoport shareholders, the return from the start of the year was 99.8%, including dividends. That kind of move invites a hard question. Back on 1 January, when analysts were split between bullish and cautious scenarios, what clues in the firm’s role in cell and gene therapy logistics could have helped you judge whether digitalization would really translate into durable cold...

      Nov 9Yahoo FinanceCYRX
      Needham raises CryoPort stock price target to $28 on revenue beat
      Nov 6Investing.comCYRX
      CryoPort Q3 Earnings Call Highlights
      Nov 6Yahoo FinanceCYRX
      CryoPort Inc (CYRX) (Q3 2026) Earnings Call Highlights: Record Clinical Pipeline and Positive ...
      Nov 6Yahoo FinanceCYRX
      CryoPort Q3 2026 Earnings Call Transcript
      Nov 5BenzingaCYRX
      Cryoport Inc earnings missed by $0.07, revenue topped estimates
      Nov 5Investing.comCYRX
      CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
      Nov 5Yahoo FinanceCYRX
      Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
      Oct 22MorningstarCYRX
      CryoPort Q2 2026 Earnings Call Transcript - CryoPort (NASDAQ:CYRX)

      CryoPort (NASDAQ:CYRX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire

      Oct 13BenzingaCYRX
      BTIG raises CryoPort stock price target to $26 on facility expansion
      Oct 13Investing.comCYRX
      Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?

      Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.

      Oct 1Yahoo FinanceCYRX
      Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals (NASDAQ:CYRX)
      Sep 25Seeking AlphaCYRX
      BTIG Remains a Buy on CryoPort (CYRX)

      Detailed price information for Cryoport Inc (CYRX-Q) from The Globe and Mail including charting and trades.

      Sep 19The Globe and MailCYRX
      Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Growth Assumptions

      The latest analyst work on Cryoport points to a higher blended fair value estimate, with price targets moving from US$17.06 to US$19.33, about a 13% uplift in the modeled target level. That shift lines up with more constructive Street commentary, as several bullish analysts highlight Cryoport’s Cell and Gene Therapy logistics and bioservices as key supports for the higher target range. As you read on, you will see how to track these shifting assumptions and what they might mean for your own...

      Aug 24Yahoo FinanceCYRX

      This is the newest page. Registered accounts read further back.